The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin.
about
Melanoma: from melanocyte to genetic alterations and clinical optionsExome sequencing identifies recurrent somatic RAC1 mutations in melanomaSkin melanocytes: biology and developmentInterventions to decrease skin cancer risk in outdoor workers: update to a 2007 systematic review.Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanomaReflectance confocal microscopy features of BRAF V600E mutated thin melanomas detected by immunohistochemistryDevelopment of a melanoma risk prediction model incorporating MC1R genotype and indoor tanning exposure: impact of mole phenotype on model performance.Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Update on Molecular Pathology of Cutaneous Melanocytic Lesions: What is New in Diagnosis and Molecular Testing for Treatment?Incidence and metastasis of cutaneous malignant melanoma with respect to ABO blood groups: a case-controlled study in northeast of China.The Epidemiology of Skin Cancer and its Trend in IranSpecification of neural crest into sensory neuron and melanocyte lineages.A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression.Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulationMutational status of naevus-associated melanomas.Cancers in Australia attributable to exposure to solar ultraviolet radiation and prevented by regular sunscreen use.Role of TRPM in melanocytes and melanoma.Acral, Superficial Spreading Melanoma Arising on Melanocytic Nevus in a Pregnant Woman: A Case Report with Review.Genetic alterations in RAS-regulated pathway in acral lentiginous melanomaThe molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia.Association Between Indoor Tanning and Melanoma in Younger Men and Women.The etiology and molecular genetics of human pigmentation disordersRational targeting of BRAF and PI3-Kinase signaling for melanoma therapy.SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesisMetastatic risk and resistance to BRAF inhibitors in melanoma defined by selective allelic loss of ATG5.Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma.Which melanoma patient carries a BRAF-mutation? A comparison of predictive models.NRAS and EPHB6 mutation rates differ in metastatic melanomas of patients in the North Island versus South Island of New Zealand.Primary Vaginal Melanoma, A Rare and Aggressive Entity. A Case Report and Review of the Literature.Modelling melanoma in mice.Update on melanoma and non-melanoma skin cancer. Annual Skin Cancer Conference 2011, Hamilton Island, Australia, 5–6 August 2011.Sorafenib in melanoma.Protein and non-protein biomarkers in melanoma: a critical update.Recent advances in cutaneous melanoma: towards a molecular model and targeted treatment.Cellular and molecular mechanisms controlling the migration of melanocytes and melanoma cells.Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspects.BRAFV600E cooperates with PI3K signaling, independent of AKT, to regulate melanoma cell proliferation.Current position of TNF-α in melanomagenesis.Genetic progression of malignant melanoma.Characteristic features of cutaneous melanoma in a dermatology referral centre in Tehran, Iran.
P2860
Q21284811-6D1CED32-FE2F-49B1-8D04-BD5BE510613FQ24607661-748F5C10-49E5-45E7-AD40-64004189D4EEQ26862340-62168E0C-50CD-4358-A2B5-6D701696B0CCQ31147330-BD6EF5C0-3D5E-45F3-AA20-DC1D7453C324Q33790743-14695CF3-44E9-4AE9-810D-AD6B1EBEBE6FQ33852985-C283975B-4E4F-4577-A306-110392AB930EQ33863654-98CACBE8-71DF-40CF-9144-9C634658C86FQ34642874-23393744-0BD4-4BE4-9E37-88EBE02F5FC6Q34928118-1BB4B0D4-3721-406B-B117-856641CDE9DBQ35091546-4C3F4D61-84D7-4C98-81B4-AA97D6AA71CEQ35906114-609FA8E0-C292-49E1-9C10-0202225D4A6EQ35957140-ACCFFE1E-E0A0-4AAE-8B20-DFD28A9A7071Q35965678-240925BC-DFED-4663-9F11-C83B36641EFDQ36050683-0FB1A112-1B59-4F4C-A478-E7418B7E2FC7Q36095004-D446A5DE-5689-4E99-AC47-C988A04E9467Q36164382-10B8FA80-1E6D-42EF-9277-BAF35E8C5218Q36174956-7F102AAA-0341-412D-9B33-EF36A253925BQ36376903-7A34F46B-AD65-401A-BCC2-34DE47216E64Q36584447-AE880DBE-3245-4E04-BE55-4A6A117378CBQ36798179-2C21DBBE-01AF-4082-A7B2-8C9A89CABC2AQ36955418-4369928D-4EC4-4FA8-A104-361F490CF511Q36959274-406B009E-5350-462B-9A24-A18D837D6D91Q37008659-120BB530-F68E-439A-9E53-A254EBE132B9Q37243181-2E444081-18CF-4961-B0DA-C4088E96E27EQ37365473-82150834-97EF-445C-AFC0-A82985F92545Q37384015-A7EB0650-8A7F-4E26-84A4-F827F8B2053FQ37392661-93EE37E2-EC48-4728-A86E-A7219D2D5B64Q37520141-7816A4B3-2C73-4B0D-90DA-4D249C6D763DQ37705279-EEC68AF1-EBD7-469F-85AD-FA709A6FA2E2Q37943839-434A23EE-CB30-47FB-AC16-76DC51944FE6Q37960908-ECC47BAE-0516-4CB4-B8E1-56F97267A73FQ37990977-58D300E8-4CF8-423A-9C14-51E801456F3CQ38050990-C618C279-751A-4CBB-9394-347270B87910Q38075009-8DE56129-1C15-44E1-91AE-64186FD040CDQ38083887-B2D5CB3A-091F-48DF-813A-24F25E4CF873Q38297995-76904A40-C698-4E3D-9A03-DF65829FD746Q38520679-E7165477-949D-4326-841B-01054D4C6F0BQ38567932-BFFE7BC9-278E-4F81-8771-6A1DB2AC78C5Q38771870-E87C3376-3002-4B3B-98BC-9ADD54555532Q38907132-9957C910-66FB-48DB-A1C4-70B5B46FCF11
P2860
The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The melanomas: a synthesis of ...... pathways, and cells of origin.
@ast
The melanomas: a synthesis of ...... pathways, and cells of origin.
@en
type
label
The melanomas: a synthesis of ...... pathways, and cells of origin.
@ast
The melanomas: a synthesis of ...... pathways, and cells of origin.
@en
prefLabel
The melanomas: a synthesis of ...... pathways, and cells of origin.
@ast
The melanomas: a synthesis of ...... pathways, and cells of origin.
@en
P2860
P50
P1476
The melanomas: a synthesis of ...... pathways, and cells of origin.
@en
P2860
P304
P356
10.1111/J.1755-148X.2011.00880.X
P577
2011-08-16T00:00:00Z